Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Enterprise Value (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Enterprise Value data on record, last reported at -$80.7 million in Q4 2025.

  • For Q4 2025, Enterprise Value rose 31.6% year-over-year to -$80.7 million; the TTM value through Dec 2025 reached -$80.7 million, up 31.6%, while the annual FY2025 figure was -$80.7 million, 31.6% up from the prior year.
  • Enterprise Value reached -$80.7 million in Q4 2025 per PLSE's latest filing, up from -$95.2 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$12.7 million in Q1 2022 and bottomed at -$119.3 million in Q1 2025.
  • Average Enterprise Value over 5 years is -$64.2 million, with a median of -$54.1 million recorded in 2023.
  • Peak YoY movement for Enterprise Value: plummeted 453.73% in 2021, then surged 35.49% in 2024.
  • A 5-year view of Enterprise Value shows it stood at -$44.4 million in 2021, then tumbled by 37.81% to -$61.1 million in 2022, then surged by 32.64% to -$41.2 million in 2023, then crashed by 186.61% to -$118.0 million in 2024, then soared by 31.6% to -$80.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Enterprise Value were -$80.7 million in Q4 2025, -$95.2 million in Q3 2025, and -$106.3 million in Q2 2025.